Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular effects of omega-3 fatty acids: Hope or hype?
Sang‐Ho Jo, Seung Hwan Han, Sang‐Hyun Kim, et al.
Atherosclerosis (2021) Vol. 322, pp. 15-23
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Cardiovascular disease in diabetes, beyond glucose
Robert H. Eckel, Karin Bornfeldt, Ira J. Goldberg
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1519-1545
Open Access | Times Cited: 138
Dietary supplements and nutraceuticals market growth during the coronavirus pandemic – Implications for consumers and regulatory oversight
Ronan Lordan
PharmaNutrition (2021) Vol. 18, pp. 100282-100282
Open Access | Times Cited: 127
Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health
Ivana Djuričić, Philip C. Calder
The Annual Review of Pharmacology and Toxicology (2023) Vol. 63, Iss. 1, pp. 383-406
Open Access | Times Cited: 46
Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid
M. John Chapman, José Luís Zamorano, Klaus G. Parhofer
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108172-108172
Open Access | Times Cited: 42
2023 Guidelines of the Taiwan Society of Cardiology on the Diagnosis and Management of Chronic Coronary Syndrome.
Kwo‐Chang Ueng, Chern‐En Chiang, Ting‐Hsing Chao, et al.
PubMed (2023) Vol. 39, Iss. 1, pp. 4-96
Closed Access | Times Cited: 26
Marine Animal Co-Products—How Improving Their Use as Rich Sources of Health-Promoting Lipids Can Foster Sustainability
João P. Monteiro, M. Rosário M. Domingues, Ricardo Calado
Marine Drugs (2024) Vol. 22, Iss. 2, pp. 73-73
Open Access | Times Cited: 10
When cardiovascular medicines should be discontinued
Konstantin A. Krychtiuk, Bernard J. Gersh, Jeffrey B. Washam, et al.
European Heart Journal (2024) Vol. 45, Iss. 23, pp. 2039-2051
Closed Access | Times Cited: 10
EPA’s pleiotropic mechanisms of action: a narrative review
John Nelson, Matthew J. Budoff, Omar R Wani, et al.
Postgraduate Medicine (2021), pp. 1-14
Open Access | Times Cited: 28
Omega-3 (n-3) Fatty Acid–Statin Interaction: Evidence for a Novel Therapeutic Strategy for Atherosclerotic Cardiovascular Disease
Ivana Djuričić, Philip C. Calder
Nutrients (2024) Vol. 16, Iss. 7, pp. 962-962
Open Access | Times Cited: 4
Fenofibrate Use Is Associated With Lower Mortality and Fewer Cardiovascular Events in Patients With Diabetes: Results of 10,114 Patients From the Korean National Health Insurance Service Cohort
Sang‐Ho Jo, Hyewon Nam, Jeongwoo Lee, et al.
Diabetes Care (2021) Vol. 44, Iss. 8, pp. 1868-1876
Open Access | Times Cited: 17
Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized Study
Kazuhiro Nakao, Teruo Noguchi, Hiroyuki Miura, et al.
Journal of Atherosclerosis and Thrombosis (2023) Vol. 31, Iss. 2, pp. 122-134
Open Access | Times Cited: 6
Improved lipid saponification for chromatographic quantification of fatty acids in porcine erythrocytes – an important lipidomic biomarker of the effectiveness of dietary fat supplementation in pigs as a large animal model for human studies
M. Czauderna, Monika Karpińska, Jarosław Woliński, et al.
Journal of Animal and Feed Sciences (2023) Vol. 32, Iss. 4, pp. 385-399
Open Access | Times Cited: 4
Effect of n-3 PUFA on left ventricular remodelling in chronic heart failure: a systematic review and meta-analysis
Jing Liu, Qingshu Meng, Liang Zheng, et al.
British Journal Of Nutrition (2022) Vol. 129, Iss. 9, pp. 1500-1509
Open Access | Times Cited: 7
When Is a Placebo Not a Placebo
Steven E. Nissen
JAMA Cardiology (2022) Vol. 7, Iss. 12, pp. 1183-1183
Closed Access | Times Cited: 6
Development of Lipid Nanoparticles Containing Omega-3-Rich Extract of Microalga Nannochlorpsis gaditana
Cristina Blanco-Llamero, Ruth Galindo, Joel Fonseca, et al.
Foods (2022) Vol. 11, Iss. 23, pp. 3749-3749
Open Access | Times Cited: 6
Marine Animal Co-Products – How Improving Their Use as Rich Sources of Health-Promoting Lipids Can Foster Sustainability
João P. Monteiro, M. Rosário M. Domingues, Ricardo Calado
(2023)
Open Access | Times Cited: 3
Formation of Self-Assembled Liquid Crystalline Nanoparticles and Absorption Enhancement of Ω-3s by Phospholipids and Oleic Acids
Sang-Won Jeon, Han-Sol Jin, Young-Joon Park
Pharmaceutics (2021) Vol. 14, Iss. 1, pp. 68-68
Open Access | Times Cited: 7
Omega-3 polyunsaturated fatty acids for the management of dyslipidemia and reduction of residual cardiovascular risk
O. Yu. Kytikovа, Т. П. Новгородцева, Yulia Denisenko, et al.
Bulletin physiology and pathology of respiration (2023), Iss. 87, pp. 124-137
Open Access | Times Cited: 2
Indications relatives à un supplément d’acides gras oméga-3 pour prévenir les maladies cardiovasculaires
N. John Bosomworth
Canadian Family Physician (2023) Vol. 69, Iss. 7, pp. e134-e144
Open Access | Times Cited: 2
THE EFFECTS OF ADSORBENT MATERIALS ON THE LIPID QUALITY OF LEMURU FISH OIL AND THE ENRICHMENT OF OMEGA-3 USING LIPASE
Raden Tina Rosmalina, W Kosasih, Sri Priatni
Jurnal Teknologi dan Industri Pangan (2021) Vol. 32, Iss. 1, pp. 16-26
Open Access | Times Cited: 5
Low Percentage of Vegetable Fat in Red Blood Cells Is Associated with Worse Glucose Metabolism and Incidence of Type 2 Diabetes
Gemma Chiva‐Blanch, Oriol Giró, Montserrat Cofán, et al.
Nutrients (2022) Vol. 14, Iss. 7, pp. 1368-1368
Open Access | Times Cited: 3
Indications for omega-3 fatty acid supplementation in prevention of cardiovascular disease
N. John Bosomworth
Canadian Family Physician (2023) Vol. 69, Iss. 7, pp. 459-468
Open Access | Times Cited: 1
Eicosapentaenoic Acid: between Cardiovascular Benefits and the Risk of Atrial Fibrillation
Filippo Egalini, Mattia Rossi, Mauro Massussi, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 24, Iss. 6, pp. 651-663
Open Access | Times Cited: 1
Fish Oil Supplements for Prevention of Cardiovascular Disease: The Jury Is Still Out: CON: Fish Oil is Useful to Prevent or Treat Cardiovascular Disease.
Hekmat B. Khoukaz, William P. Fay
PubMed (2021) Vol. 118, Iss. 3, pp. 219-225
Closed Access | Times Cited: 3
Effects of Whey Protein, Omega-3 Fatty Acid and Roux-En-Y Gastric Bypass on Body Weight, Biochemical Parameters and Organ Functions in an Obese Rat Model: Experimental Research
Fatma Mert-Biberoğlu, Nihal Zekiye Erdem, Yaşar Özdenkaya, et al.
Obesity Surgery (2023) Vol. 33, Iss. 5, pp. 1553-1563
Closed Access
Page 1 - Next Page

Scroll to top